[Fibrinolytic therapy in ischemic brain infarct]

Dtsch Med Wochenschr. 1987 Apr 10;112(15):603-8. doi: 10.1055/s-2008-1068107.
[Article in German]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arterial Occlusive Diseases / drug therapy
  • Cerebral Hemorrhage / chemically induced
  • Cerebral Infarction / drug therapy*
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Plasminogen Activators / therapeutic use
  • Recombinant Proteins / therapeutic use
  • Risk
  • Streptokinase / therapeutic use
  • Tissue Plasminogen Activator / therapeutic use
  • Urokinase-Type Plasminogen Activator / therapeutic use

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • Streptokinase
  • Plasminogen Activators
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator